These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Lipid profiles in pediatric thoracic transplant recipients are determined by their immunosuppressive regimens. Law YM, Yim R, Agatisa P, Boyle GJ, Miller SA, Lawrence K, Webber SA. J Heart Lung Transplant; 2006 Mar; 25(3):276-82. PubMed ID: 16507419 [Abstract] [Full Text] [Related]
9. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease. Goel PK, Bharti BB, Pandey CM, Singh U, Tewari S, Kapoor A, Garg N, Sinha N. Indian Heart J; 2003 Nov; 55(3):234-40. PubMed ID: 14560932 [Abstract] [Full Text] [Related]
17. Lipid disorder and transplant coronary artery disease in long-term survivors of heart transplantation. Park JW, Merz M, Braun P, Vermeltfoort M. J Heart Lung Transplant; 1996 Jun; 15(6):572-9. PubMed ID: 8803754 [Abstract] [Full Text] [Related]
18. Impact of fluvastatin on hyperlipidemia after renal transplantation. Tokumoto T, Tanabe K, Ishida H, Shimmura H, Ishikawa N, Goya N, Akiba T, Toma H. Transplant Proc; 2004 Sep; 36(7):2141-4. PubMed ID: 15518777 [Abstract] [Full Text] [Related]
19. Safety and efficacy of low dose simvastatin in cardiac transplant recipients treated with cyclosporine. Vanhaecke J, Van Cleemput J, Van Lierde J, Daenen W, De Geest H. Transplantation; 1994 Jul 15; 58(1):42-5. PubMed ID: 8036706 [Abstract] [Full Text] [Related]
20. Lability of serum low-density lipoprotein cholesterol levels during screening in subgroup of Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) cohort. Clearfield MB, Weis SE, Willis JM, Vasenius KA, McConathy WJ. J Am Osteopath Assoc; 2002 Jul 15; 102(7):377-84. PubMed ID: 12138952 [Abstract] [Full Text] [Related] Page: [Next] [New Search]